AIM ImmunoTech Director David Chemerow Receives 2,800-Share Award

What Happened David I. Chemerow, a director of AIM ImmunoTech Inc. (AIM), was granted 2,800 shares on February 5, 2026. The award was reported at $1.23 per share, for a total reported value of $3,444. This transaction is coded as an award/grant (A) — a company-issued acquisition rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-02-05; reported/filer date: 2026-02-06 (timely under the Form 4 two-business-day rule).
• Price reported: $1.23 per share; total value: $3,444.
• Transaction code: A (grant/award).
• Shares owned after transaction: Not specified in the provided filing excerpt — see the full Form 4 for post-transaction holdings.
• No 10b5-1 plan, tax-withholding, or other footnotes were indicated in the supplied transaction details.

Context Grants/awards to directors are commonly part of compensation or service arrangements and differ from open-market purchases that might signal personal buying conviction. The reported value here is modest, so it is likely routine compensation; review future filings or company disclosures for additional context or larger insider activity.